Teladoc Health, Inc.
TDOC Healthcare Health Information Services
Teladoc Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, down 1.54% from fiscal 2024. In the quarter to June 2026, revenue fell 3.95%, EPS fell 10.5%, free cash flow fell 27.1% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow TDOC
Teladoc Health, Inc. (TDOC) P/E ratio
Teladoc Health, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MDRX Veradigm Inc. compare | n/m |
| SOPH SOPHiA GENETICS SA compare | n/m |
| TDOC Teladoc Health, Inc. | n/m |
| CERT Certara, Inc. compare | n/m |
| OMCL Omnicell, Inc. compare | 41.6× |
| HSTM HealthStream, Inc. compare | 46.0× |
| GDRX GoodRx Holdings, Inc. compare | 62.7× |
| PHR Phreesia, Inc. compare | 64.4× |
| OMDA Omada Health, Inc. compare | 252× |
| Health Information Services industry median | 39.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)